[
  {
    "ts": null,
    "headline": "Gilead Sciences (GILD) Gains As Market Dips: What You Should Know",
    "summary": "In the most recent trading session, Gilead Sciences (GILD) closed at $91.09, indicating a +0.44% shift from the previous trading day.",
    "url": "https://finnhub.io/api/news?id=5b572ee58bc829f9ffa5a23e6ee8c63a26f5b8eed6c1c67c3c0c1ccda0d733e6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734649218,
      "headline": "Gilead Sciences (GILD) Gains As Market Dips: What You Should Know",
      "id": 132060796,
      "image": "https://media.zenfs.com/en/zacks.com/1a018a29aef5adbf5b4319f32058e209",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "In the most recent trading session, Gilead Sciences (GILD) closed at $91.09, indicating a +0.44% shift from the previous trading day.",
      "url": "https://finnhub.io/api/news?id=5b572ee58bc829f9ffa5a23e6ee8c63a26f5b8eed6c1c67c3c0c1ccda0d733e6"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences : Submits New Drug Application to U.S. Food and Drug Administration for Twice-Yearly Lenacapavir for HIV Prevention",
    "summary": "Lenacapavir Named 2024 Breakthrough of the Year by Science Magazine Foster City, Calif., December 19, 2024 - Gilead Sciences, Inc. today announced the company completed New Drug...",
    "url": "https://finnhub.io/api/news?id=6eda77f7ea17e7f6aa8aa9bebe7fbe63b595f0636f25f05aeb3efc29a449b837",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734628843,
      "headline": "Gilead Sciences : Submits New Drug Application to U.S. Food and Drug Administration for Twice-Yearly Lenacapavir for HIV Prevention",
      "id": 132059051,
      "image": "",
      "related": "GILD",
      "source": "Finnhub",
      "summary": "Lenacapavir Named 2024 Breakthrough of the Year by Science Magazine Foster City, Calif., December 19, 2024 - Gilead Sciences, Inc. today announced the company completed New Drug...",
      "url": "https://finnhub.io/api/news?id=6eda77f7ea17e7f6aa8aa9bebe7fbe63b595f0636f25f05aeb3efc29a449b837"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences Inc. stock outperforms competitors on strong trading day",
    "summary": "Gilead Sciences Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=dc336dacc7b59772a907a2218413f448928534327fcf26edd5e9f1efb7d83497",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734626520,
      "headline": "Gilead Sciences Inc. stock outperforms competitors on strong trading day",
      "id": 132148533,
      "image": "",
      "related": "GILD",
      "source": "MarketWatch",
      "summary": "Gilead Sciences Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=dc336dacc7b59772a907a2218413f448928534327fcf26edd5e9f1efb7d83497"
    }
  },
  {
    "ts": null,
    "headline": "Assembly Biosciences Shares Rise 19% After Gilead Investment, Funding",
    "summary": "By Chris Wack Assembly Biosciences shares were up 19% at $16.01 after receiving an equity investment and accelerated funding from Gilead Sciences. Shares of the biotechnology company hit a...",
    "url": "https://finnhub.io/api/news?id=2b06be7ba7a6c8c98903312d86696d2f0ee0651a501363f378153febdb4d1ec7",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734603976,
      "headline": "Assembly Biosciences Shares Rise 19% After Gilead Investment, Funding",
      "id": 132052119,
      "image": "",
      "related": "GILD",
      "source": "Finnhub",
      "summary": "By Chris Wack Assembly Biosciences shares were up 19% at $16.01 after receiving an equity investment and accelerated funding from Gilead Sciences. Shares of the biotechnology company hit a...",
      "url": "https://finnhub.io/api/news?id=2b06be7ba7a6c8c98903312d86696d2f0ee0651a501363f378153febdb4d1ec7"
    }
  },
  {
    "ts": null,
    "headline": "Assembly Biosciences Gets $30.1 Million Equity Investment, Funding From Gilead",
    "summary": "By Chris Wack Assembly Biosciences said it has received a $20.1 million equity investment from Gilead Sciences, along with $10 million in accelerated funding. Gilead is buying the additional...",
    "url": "https://finnhub.io/api/news?id=3c40b50dd38fc3a78f6cc7fd1a3c0b1dc3e64c4498e280232581af5263f1231e",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734597509,
      "headline": "Assembly Biosciences Gets $30.1 Million Equity Investment, Funding From Gilead",
      "id": 132050807,
      "image": "",
      "related": "GILD",
      "source": "Finnhub",
      "summary": "By Chris Wack Assembly Biosciences said it has received a $20.1 million equity investment from Gilead Sciences, along with $10 million in accelerated funding. Gilead is buying the additional...",
      "url": "https://finnhub.io/api/news?id=3c40b50dd38fc3a78f6cc7fd1a3c0b1dc3e64c4498e280232581af5263f1231e"
    }
  },
  {
    "ts": null,
    "headline": "Assembly Biosciences Gets $30.1M Equity Investment, Funding From Gilead",
    "summary": "Assembly Biosciences Gets $30.1M Equity Investment, Funding From Gilead",
    "url": "https://finnhub.io/api/news?id=f7fb1777042785a9e3516ec43819688e7b2572a9ef72937786807429fc67cd60",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734596580,
      "headline": "Assembly Biosciences Gets $30.1M Equity Investment, Funding From Gilead",
      "id": 132148535,
      "image": "",
      "related": "GILD",
      "source": "MarketWatch",
      "summary": "Assembly Biosciences Gets $30.1M Equity Investment, Funding From Gilead",
      "url": "https://finnhub.io/api/news?id=f7fb1777042785a9e3516ec43819688e7b2572a9ef72937786807429fc67cd60"
    }
  }
]